Paradigm Financial Partners, LLC Bristol Myers Squibb CO Transaction History
Paradigm Financial Partners, LLC
- $937 Million
- Q3 2025
A detailed history of Paradigm Financial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 8,564 shares of BMY stock, worth $400,880. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,564
Previous 11,073
22.66%
Holding current value
$400,880
Previous $512,000
24.61%
% of portfolio
0.04%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...